Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C and Liraglutide in Type 1 Diabetes
NCT02109315Phase 1Withdrawn
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liraglutide in type 1 diabetes mellitus (T1D) (2 arms). Primary endpoint: Flow-mediated dilation at 8 weeks. Planned start May 2014; status: withdrawn.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02109315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02109315.